SCHEMBL16474355

SCHEMBL16474355

CCOC(=O)c1cc2cc(OC(=O)c3ccc(OC(=O)c4ccc(C)cc4)cc3)ccc2c2c1C=CC(c1ccccc1)(c1ccc(N3CCCCC3)cc1)O2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
METAP1 P53582 1/20 0.36
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SIRT2 Q8IXJ6 3/20 0.34
SIRT1 Q96EB6 2/20 0.34
MAPT P10636 5/20 0.34
KMT2A Q03164 4/20 0.34
GAA P10253 4/20 0.34
MEN1 O00255 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 1/20 0.33
RARA P10276 2/20 0.33
RARB P10826 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16479408 0.95 METAP1 (0.35) LMNAMETAP1THRBSMN1; SMN2SIRT2
SCHEMBL16474341 0.89 SIRT2 (0.34) METAP1THRBSMN1; SMN2SIRT2SIRT1
SCHEMBL15277648 0.89 SIRT2 (0.37) LMNAMETAP1SMN1; SMN2SIRT2SIRT1
SCHEMBL13005296 0.88 MAPT (0.42) LMNATHRBSMN1; SMN2MAPTKMT2A
SCHEMBL15277649 0.88 ALDH1A1 (0.36) LMNAMETAP1SMN1; SMN2SIRT2SIRT1
SCHEMBL16474343 0.88 ALDH1A1 (0.34) LMNASMN1; SMN2SIRT2SIRT1MAPT
SCHEMBL16479410 0.86 ALOX5 (0.39) LMNAMETAP1SIRT2SIRT1MAPT
SCHEMBL16474344 0.86 SIRT2 (0.34) LMNAMETAP1SMN1; SMN2SIRT2SIRT1
SCHEMBL18961301 0.85 ALDH1A1 (0.36) LMNAMETAP1SMN1; SMN2SIRT2SIRT1
SCHEMBL18971203 0.85 ALDH1A1 (0.39) LMNAMETAP1SMN1; SMN2SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 LMNA 1838/4885METAP1 4382/4885THRB 1701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.